RECENT NEWS
Multi-million pound UK-wide platform into cancer immunotherapy launches
A nationwide team of universities, hospitals and industry led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust, have launched a new platform to understand immunotherapy response and side effects in cancer, with the National Pathology Imaging Co-operative playing a critical role.
Proteotype wins £1.5m grant to develop Enlighten cancer test
Proteotype Diagnostics Ltd, in collaboration with the University of Southampton, has been awarded £1.5 million in funding from the National Institute for Health and Care Research (NIHR) and the Office for Life Sciences (OLS). The grant will support clinical validation of Proteotype's novel Enlighten multi-cancer early detection test, a revolutionary approach to detecting early-stage cancers by focusing on the body's response to tumour development.
Partnership to develop new diagnostic technology
A new partnership between Roche Diagnostics UK and Ireland, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, will play a key role in developing cutting-edge medical diagnostics.
£11m to fund new UK projects for earlier cancer diagnosis
The National Institute for Health and Care Research (NIHR) has announced almost £11 million of new funding for projects which aim to help increase the early detection and diagnosis of cancer.
RCPath hosting virtual AMR conference on International Pathology Day
The Royal College of Pathologists (RCPath) is marking International Pathology Day this year on Wednesday 6 November with a day-long virtual conference looking at the issue of antimicrobial resistance (AMR).
Synnovis cyberattack: patient services restored
The final stages of recovery following the cyber attack on pathology services provider Synnovis in June are almost complete, which means nearly all services are now up and running.
MHRA launches 2024/25 business plan
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its ambitious new business plan for 2024/25, setting out the agency’s core focus of enabling access to innovative healthcare products while ensuring delivery for all who need its services – patients and the public, healthcare professionals, researchers and developers.
New spinning disk microscopy collaboration
Italian microsopy manufacturer CrestOptics and Leica Microsystems have announced a new collaboration, bringing CrestOptics’ CICERO spinning disk unit technology to Leica Microsystems’ new THUNDER Imager Cell Spinning Disk system.
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
Netherlands-based diagnostic firm QIAGEN has announced the launch of the QIAcuityDx Digital PCR System, a new addition to its digital PCR portfolio which is expanding into clinical diagnostics. The new system streamlines clinical testing by providing highly precise, absolute quantitation of target DNA and RNA, supporting applications with less invasive liquid biopsies.
West Yorkshire and Harrogate hospitals share test results using Clinisys ICE OpenNet
Clinicians working at five of the six NHS Trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access pathology and other diagnostic test results from across their network, following a summer roll-out of Clinisys’ ICE OpenNet.
New initiatives from Proscia to further advance AI in pathology
Digital pathology firm Proscia has announced the launch of Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organisations to accelerate the discovery and development of novel therapies and diagnostics.
Genomics England testing newborns for over 200 conditions in new study
Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.
Beckman Coulter Life Sciences names Joe Fox as President
Beckman Coulter Life Sciences has announced the appointment of Joe Fox as President of the company, effective immediately.
Report examines regulatory future for medical devices and diagnostics
A new white paper report commissioned by Abbott seeks to provide a constructive contribution to ongoing policy and legislative developments for medical devices and diagnostics. Its release comes as the new UK Government looks to refocus healthcare more towards prevention and closer to home through the use of the latest innovative technologies, and with a focus on regulatory innovation.
Research heralds new era for genetics
Research led by scientists at Queen Mary University of London is heralding in a new era for genetic sequencing and testing.
New partnership to advance predictive AI models in oncology trials
BioAI, a biotechnology company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers.
Beyond conventional pathology, label-free histology meets AI
A collaborative research team led by Professor Chulhong Kim and Professor Chan Kwon Jung of Seoul St. Mary’s Hospital, Catholic University of Korea, has developed an artificial intelligence (AI) system to analyse the label-free photoacoustic histological images of human liver cancer tissues.
Mindpeak targets international growth after securing $15.3M in funding
AI-powered pathology solutions provider Mindpeak has announced it has raised $15.3 million in a Series A funding round. This new investment will enable the company to further expand the commercialisation of its recently expanded suite of technologies across several new territories.
Owlstone Medical agrees research collaboration with US FDA
‘Breath biopsy’ firm Owlstone Medical has announced it has entered into a Research Collaboration Agreement with the US FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL). The goal of the collaboration is to develop methods for the confident identification of individual chemicals in the complex mixture of breath.
RCPath launches Patient Safety and Quality Strategy
The Royal College of Pathologists (RCPath) has published a new Patient Safety and Quality Strategy as part of its ongoing aim to improve patient safety.
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
Run 15 Variant Classification and Clinical Impact of Variability - webinar
Online
16 September, 2025
GenQA at ESCV 2025
Thessaloniki Concert Hall
17 September, 2025
International nomenclature for genomics for complex numerical and structural abnormalities - webinar
Online
18 September, 2025
IBMS Congress
The International Convention Centre (ICC), Birmingham
22-25 September, 2025
Diagnostics North East Conference 2025
The Catalyst, Newcastle
3 October